Details for Patent: 7,699,609

Which drugs does patent 7,699,609 protect, and when does it expire?

Patent 7,699,609 protects ARESTIN and is included in one NDA.

This patent has sixteen patent family members in thirteen countries.

Summary for Patent: 7,699,609

Title:	Dispensing apparatus and cartridge with deformable tip
Abstract:	A device for the treatment of periodontal disease. The device includes a handle that has a configuration familiar to dental professionals and a cartridge that is locked into the handle when use, typically delivery of a composition to a periodontal pocket, is desired. The cartridge provides for effective delivery of compositions, such as agents, as its tip is deformable, typically from a circular to an oval shape so as to flatten. The deformation may be made either manually, by the dental professional, or upon contact with teeth or other tissues, whereby this flattened tip can penetrate deeply into periodontal pockets for quick and direct application of the composition, for example, therapeutic agents.
Inventor(s):	Lawter; James R. (Yardley, PA), Lanzilotti; Michael G. (Newtown, PA), Bates; Mark (Westwood, MA), Hunter; Gregory H. (Dover, MA)
Assignee:	Orapharma, Inc. (Warminster, PA)
Application Number:	10/763,632
Patent Claim Types: see list of patent claims	Device; Use;

Drugs Protected by US Patent 7,699,609

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Orapharma	ARESTIN	minocycline hydrochloride	POWDER, EXTENDED RELEASE;DENTAL	050781-001	Feb 16, 2001		RX	Yes	Yes			Y

International Family Members for US Patent 7,699,609

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Argentina	039205
Australia	2003223384
Australia	2009201777
Brazil	0308859
Canada	2479995
Colombia	5611079
Cyprus	1114425